Becker Muscular Dystrophy

Common Name(s)

Becker Muscular Dystrophy

Becker muscular dystrophy (BMD) is an inherited condition that primarily affects males and causes progressive weakness and wasting of the skeletal and cardiac (heart) muscles. The age of onset and rate of progression can vary among affected people. Muscle weakness usually becomes apparent between the ages of 5 and 15. In some cases, heart involvement (cardiomyopathy) is the first sign. BMD is caused by a mutation in the DMD gene and is inherited in an X-linked recessive manner. BMD is very similar to Duchenne muscular dystrophy, except that symptoms begin later and progress at a slower rate. There is no cure for this condition, and treatment aims to relieve symptoms to help quality of life. People with BMD may survive into their 40s or beyond.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Becker Muscular Dystrophy" for support, advocacy or research.

Neuromuscular Disease Association of China

There are over 40 different types of Muscular Dystrophy and related Neuromuscular conditions.These conditions are characterised by loss of muscular strength,as progressive muscle wasting or nerve

Last Updated: 21 May 2010

View Details
Parent Project Muscular Dystrophy

Parent Project Muscular Dystrophy’s mission is to end Duchenne. We accelerate research, raise our voices in Washington, demand optimal care for all young men, and educate the global community.

Last Updated: 15 Nov 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Becker Muscular Dystrophy" for support, advocacy or research.

Neuromuscular Disease Association of China

There are over 40 different types of Muscular Dystrophy and related Neuromuscular conditions.These conditions are characterised by loss of muscular strength,as progressive muscle wasting or nerve

http://www.mdachina.org

Last Updated: 21 May 2010

View Details
Parent Project Muscular Dystrophy

Parent Project Muscular Dystrophy’s mission is to end Duchenne. We accelerate research, raise our voices in Washington, demand optimal care for all young men, and educate the global community.

http://www.parentprojectmd.org

Last Updated: 15 Nov 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Becker Muscular Dystrophy" returned 114 free, full-text research articles on human participants. First 3 results:

Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients.
 

Author(s): Tomoko Lee, Yasuhiro Takeshima, Noriko Kusunoki, Hiroyuki Awano, Mariko Yagi, Masafumi Matsuo, Kazumoto Iijima

Journal: J. Hum. Genet.. 2014 Jan;59(1):46-50.

 

Duchenne and Becker muscular dystrophies (DMD/BMD) are X-linked inherited muscular disorders caused by mutations in the dystrophin gene. Two-thirds of DMD cases are thought to be caused by inheritance from carrier mothers and this study aimed to clarify and compare the carrier frequency ...

Last Updated: 27 Jan 2014

Go To URL
Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers.
 

Author(s): Steven Schade van Westrum, Lukas Dekker, Rob de Haan, Erik Endert, Ieke Ginjaar, Marianne de Visser, Anneke van der Kooi

Journal:

 

Cardiomyopathy is reported in Duchenne and Becker muscle dystrophy patients and female carriers. Brain Natriuretic peptide (BNP) is a hormone produced mainly by ventricular cardiomyocytes and its production is up regulated in reaction to increased wall stretching. N-terminal-proBNP ...

Last Updated: 22 Jul 2013

Go To URL
Cardiac resynchronization therapy in becker muscular dystrophy.
 

Author(s): George Andrikopoulos, Spiros Kourouklis, Chrysanthi Trika, Stylianos Tzeis, Ioannis Rassias, Christos Papademetriou, Apostolos Katsivas, George Theodorakis

Journal: Hellenic J Cardiol. ;54(3):227-9.

 

A 44-year-old male patient with known Becker muscular dystrophy and concomitant non-ischemic dilated cardiomyopathy presented to our department because of worsening heart failure and presyncope. Upon admission, the patient was in New York Heart Association functional class III despite ...

Last Updated: 20 May 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Becker Muscular Dystrophy" returned 5 free, full-text review articles on human participants. First 3 results:

Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).
 

Author(s): Richard S Finkel

Journal: J. Child Neurol.. 2010 Sep;25(9):1158-64.

 

Nucleotide changes within an exon can alter the trinucleotide normally encoding a particular amino acid, such that a new ''stop'' signal is transcribed into the mRNA open reading frame. This causes the ribosome to prematurely terminate its reading of the mRNA, leading to nonsense-mediated ...

Last Updated: 6 Sep 2010

Go To URL
Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.
 

Author(s): Rita Wen Kaspar, Hugh D Allen, Federica Montanaro

Journal: J Am Acad Nurse Pract. 2009 May;21(5):241-9.

 

To review the current understanding of the pathophysiology of dilated cardiomyopathy (DCM) in patients with Duchenne and Becker muscular dystrophies, assessment of cardiac dysfunction for these patients, and the recommended pharmacological treatment options and ongoing research directions.

Last Updated: 12 May 2009

Go To URL
Cardiac involvement in Becker muscular dystrophy.
 

Author(s): Josef Finsterer, Claudia Stöllberger

Journal: Can J Cardiol. 2008 Oct;24(10):786-92.

 

The present review gives an overview of the clinical and subclinical manifestations of cardiac involvement (CI) in Becker muscular dystrophy (BMD), its pathophysiological background, diagnostic possibilities and therapeutic options for CI in BMD patients and carriers. CI may be subclinical ...

Last Updated: 8 Oct 2008

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

L-citrulline and Metformin in Becker's Muscular Dystrophy
 

Status: Recruiting

Condition Summary: Becker's Muscular Dystrophy (BMD)

 

Last Updated: 17 Dec 2013

Go to URL
Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
 

Status: Recruiting

Condition Summary: Becker Muscular Dystrophy

 

Last Updated: 23 Aug 2013

Go to URL
Ramipril Versus Carvedilol in Duchenne and Becker Patients
 

Status: Recruiting

Condition Summary: Duchenne Muscular Dystrophy; Becker Muscular Dystrophy

 

Last Updated: 8 Jan 2009

Go to URL